Role Of Panchakarma And Ayurvedic Drugs In The Management Of Amavata: A Case Study

Authors

  • Swati Tikale, Shweta Parwe, Punam Sawarkar, Madhulika Tiwari, Ranjit S. Ambad, Nandkishor Bankar

Abstract

Amavata Is The Most Common Disease Caused By Agni Dehydration (Digestive Fire), Which Leads To The Accumulation Of Ama (Bio-Toxin) And Regeneration Of Vata Dosha. Amavata Is Mainly Caused By The Prakopa Of Vata Dosha And The Production Of Ama And Resides In Shleshmasthana (Asthisandhi) Thar Results In "Amavata". In Terms Of Its Therapeutic Properties It Is Similar To That Of Amavata. Rheumatoid Arthritis Is An Autoimmune Disease That Causes Chronic Polyarthritis. In Modern Science Treatments Include The Production Of Nsaid's (Nonsteroidal Anti-Inflammatory Drugs), Glucocorticoids, Dmard's (Disease Modifying Ant Rheumatic Drugs), Immunosuppressant Drugs, And Long-Term Use Leading To Many Side Effects. Ayurveda Can Provide A Better Result Without The Side Effects. Acharya Chakradatta Described The Chikisa Sutra For The Healing Of The Amavata, Which Contains Panchakarma Procedures Such As Langhana, Sweden, Virechana, Snehapana And Basti And The Use Of Herbal Remedies With Tikta, Katu Rasa And Deanaana. These Therapies Benefit From Amapachana, Vatashamana, Strotoshodhana And Sthana Balya. By Using This Chikisha Sutra In Operation The Amavata Case Was Successfully Managed. There Has Been Significant Improvement In Symptoms And Signs After Treatment And No Problem Was Found During Treatment.

Conclusion

From This Case Study It Can Be Say That Amavata Can Be Effectively And Safely Treated By Using Various Panchakarma Procedure And Shamana Medicine That Is Mentioned As Chikitsa Siddhant By Acharya Chakradatta. This Is Effect Seen In This Case And It Requires More Studies To Substantiate Effect Of Ayurveda Treatment In Amavata.

Published

2021-07-21

How to Cite

Swati Tikale, Shweta Parwe, Punam Sawarkar, Madhulika Tiwari, Ranjit S. Ambad, Nandkishor Bankar. (2021). Role Of Panchakarma And Ayurvedic Drugs In The Management Of Amavata: A Case Study. Drugs and Cell Therapies in Hematology, 10(1), 797–802. Retrieved from https://www.dcth.org/index.php/journal/article/view/165

Issue

Section

Articles